Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

TRAVERE THERAPEUTICS INC (TVTX)

283 + Investors. Track Smart Money conviction in TVTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +38
Streak
2Q ▲
Buyers last Q
56%

Smart Money Signals — TVTX

Based on 266 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added TVTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
266 hedge funds hold TVTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +41% more funds vs a year ago

fund count last 6Q
+77 new funds entered over the past year (+41% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 56% buying

167 buying129 selling
Last quarter: 167 funds bought or added vs 129 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+18 vs last Q)

new funds entering per quarter
Funds opening a new TVTX position: 48 → 39 → 53 → 71. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

45% of holders stayed for 2+ years

■ 45% conviction (2yr+) ■ 24% medium ■ 31% new
121 out of 266 hedge funds have held TVTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +63% but shares only +2% — price-driven

Value
+63%
Shares
+2%
Last quarter: the total dollar value of institutional holdings rose +63%, but actual share count only changed +2%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

45 → 48 → 39 → 53 → 71 new funds/Q
New funds entering each quarter: 48 → 39 → 53 → 71. A growing number of institutions are discovering TVTX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 55% of holders stayed 2+ years

■ 55% veterans ■ 10% 1-2yr ■ 35% new
Of 283 current holders: 156 (55%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 44% AUM from top-100 funds

44% from top-100 AUM funds
34 of 266 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in TVTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.2
out of 10
Moderate Exit Risk
Exit risk score 4.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TVTX

In 2025 Q4, 167 hedge funds were net buyers of TVTX (71 opened a new position, 96 added to an existing one), while 129 reduced or exited (96 trimmed, 33 sold completely) — a 56% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 44% of total institutional value in TVTX is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +38 funds (more new holders than closures). Total institutional holders: 266.

Hedge Fund Ownership: TVTX

How many hedge funds hold TVTX — quarterly history vs. share price
Quarterly hedge fund ownership of TVTX vs. share price

Market Analysis: TVTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TVTX

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

45 top-rated funds 1 high-conviction
Consensus
7.2
/ 10
breadth
×
Elite
2.2
/ 10
conviction
Hedge Fund Positioning: TVTX
2026 Q1 Stats Unlock in 9 days 283 + Investors

Track Smart Money conviction in TVTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 283 245 15.51%
13F Shares 106M 104M 2.45%
Total Value $4.04B $2.48B 63.38%
New Positions 74 58 +16
Increased Positions 112 85 +27
Closed Positions 33 30 +3
Reduced Positions 120 95 +25
Total Calls 10 15 -33.33%
Total Puts 13 10 30.0%
PUT/CALL Ratio 1.3 0.67 Bearish

Statistics: TVTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

283 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TVTX. Verified SEC 13F-HR filings.

Top 25 institutional holders of TVTX — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Palisades Investment Partners, LLC 2.97% 255,240 $7.6M
2 EMERALD ADVISERS, LLC 1.46% 1,557,196 $46.3M
3 EMERALD MUTUAL FUND ADVISERS TRUST 1.36% 945,033 $28.1M
4 Stephens Investment Management Group LLC 0.73% 1,798,466 $53.4M
5 Lisanti Capital Growth, LLC 0.36% 48,185 $1.4M
6 CenterBook Partners LP 0.25% 157,122 $4.7M
7 Hillsdale Investment Management Inc. 0.15% 182,320 $5.4M
8 OAK RIDGE INVESTMENTS LLC 0.13% 67,323 $2.0M
9 Bayforest Capital Ltd 0.12% 3,512 $104K
10 S&CO INC 0.10% 56,000 $2K
11 PROFUND ADVISORS LLC 0.07% 67,918 $2.0M
12 Y-Intercept (Hong Kong) Ltd 0.07% 117,361 $3.5M
13 Candriam S.C.A. 0.06% 369,995 $11.0M
14 China Universal Asset Management Co., Ltd. 0.04% 19,825 $589K
15 BURNEY CO/ 0.04% 39,724 $1.2M
16 Penn Capital Management Company, LLC 0.03% 12,676 $377K
17 Aberdeen Group plc 0.03% 557,147 $16.6M
18 E Fund Management Co., Ltd. 0.02% 19,162 $569K
19 Diversified Trust Co 0.02% 28,161 $837K
20 Pictet Asset Management Holding SA 0.02% 529,757 $14.7M
21 AlphaQuest LLC 0.01% 6,799 $260K
22 Universal- Beteiligungs- und Servicegesellschaft mbH 0.01% 246,648 $7.3M
23 NEW YORK STATE COMMON RETIREMENT FUND 0.01% 293,357 $8.7M
24 ALPS ADVISORS INC 0.01% 75,096 $2.2M
25 Jefferies Financial Group Inc. 0.01% 50,000 $1.5M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — TRAVERE THERAPEUTICS INC (TVTX)

What does the Smart Money Trend signal show for TVTX?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added TVTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TVTX?

Slight buying edge — 56% buying: Last quarter: 167 funds bought or added vs 129 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for TVTX holders?

Elite ownership — 44% AUM from top-100 funds: 34 of 266 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in TVTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held TVTX?

45% of holders stayed for 2+ years: 121 out of 266 hedge funds have held TVTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.